Cerebrolysin vs NSI-189

Overview

Cerebrolysin is primarily a pain management peptide, while NSI-189 is used for cognitive enhancement.

This page compares Cerebrolysin and NSI-189 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. Cerebrolysin is categorised under Pain Management, while NSI-189 falls under Cognitive Enhancement. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Cerebrolysin: not FDA-approved; treated as a research compound. NSI-189: not FDA-approved; treated as a research compound.

Dosing. Cerebrolysin is typically dosed at 5-10 ml (multiple weekly). NSI-189 is typically dosed at Research protocols vary (research).

Can you stack them?

Some protocols combine peptides, but stacking Cerebrolysin and NSI-189 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Cerebrolysin and NSI-189?

Cerebrolysin is primarily a pain management peptide, while NSI-189 is used for cognitive enhancement. Cerebrolysin is not FDA-approved; generally classified as a research compound, whereas NSI-189 is not FDA-approved; generally classified as a research compound.

What is Cerebrolysin used for?

Neuropathic pain support.

What is NSI-189 used for?

Neurogenesis, depression.

Can you take Cerebrolysin and NSI-189 together?

Some users combine peptides within a single protocol, but stacking Cerebrolysin and NSI-189 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is Cerebrolysin or NSI-189 FDA-approved?

Cerebrolysin is not FDA-approved; generally classified as a research compound. NSI-189 is not FDA-approved; generally classified as a research compound.